Postoperative short-term outcomes | Preoperative intestinal dysbacteriosis | Sum | x2/H | P | ||
---|---|---|---|---|---|---|
Grade 1 (n = 268) | Grade 2 (n = 58) | Grade 3 (n = 27) | ||||
Early postoperative diarrhoea | 38 (14.2%) | 25 (43.1%) | 13 (48.1%) | 76 (21.5%) | 32.704 |  < 0.001†|
Surgical complications | 13 (4.9%) | 6 (10.3%) | 5 (18.5%) | 24 (6.8%) | 8.481 | 0.004†|
 Incision infections | 5 (1.9%) | 1 (1.7%) | 2 (7.4%) | 8 (2.3%) | 2.091 | 0.148†|
 Abdominal/Pelvic infections | 5 (1.9%) | 2 (3.4%) | 3 (11.1%) | 10 (2.8%) | 6.470 | 0.011†|
 Anastomotic leakage | 4 (1.5%) | 3 (5.2%) | 3 (11.1%) | 10 (2.8%) | 9.429 | 0.002†|
Pulmonary infections | 16 (6.0%) | 7 (12.1%) | 6 (22.2%) | 29 (8.2%) | 9.733 | 0.002†|
Urinary tract infections | 3 (1.1%) | 1 (1.7%) | 0 (0.0%) | 4 (1.1%) | 0.049 | 0.824†|
Fever of unknown origin | 2 (0.7%) | 1 (1.7%) | 0 (0.0%) | 3 (0.8%) | 0.002 | 0.963†|
Total postoperative complications | 34 (12.7%) | 15 (25.9%) | 11 (40.7%) | 60 (17.0%) | 17.481 |  < 0.001†|
Length of postoperative stay (days) | 6.0 (3–32) | 6.0 (3–32) | 6.0 (3–31) | 6.0 (3–16) | 1.867 | 0.393 |
Length of antibiotics therapy (days) | 2.0 (1–24) | 2.0 (1–24) | 3.0 (2–20) | 2.0 (1–18) | 9.791 | 0.007‡ |
Antibiotics regimen§, n(%) | ||||||
 Cefoxitin or Cefmetazole | 260 (97.0%) | 54 (93.1%) | 22 (81.5%) | 336 (95.2%) | 21.163 | 0.002 |
 Cefoperazone/sulbactam (Sulperazon) | 3 (1.1%) | 1 (1.7%) | 3 (11.1%) | 7 (2.0%) |  |  |
 Piperacillin/tazobactam (Tazocin) | 2 (0.7%) | 2 (3.4%) | 2 (7.4%) | 6 (1.7%) |  |  |
 Moxifloxacin (Avelox) | 3 (1.1%) | 1 (1.7%) | 0 (0.0%) | 4 (1.1%) |  |  |